CO4980854A1 - Inhibidores de celulas b particularmente amidas, proceso par su produccion y composiciones farmaceuticas que los contiene - Google Patents

Inhibidores de celulas b particularmente amidas, proceso par su produccion y composiciones farmaceuticas que los contiene

Info

Publication number
CO4980854A1
CO4980854A1 CO99007017A CO99007017A CO4980854A1 CO 4980854 A1 CO4980854 A1 CO 4980854A1 CO 99007017 A CO99007017 A CO 99007017A CO 99007017 A CO99007017 A CO 99007017A CO 4980854 A1 CO4980854 A1 CO 4980854A1
Authority
CO
Colombia
Prior art keywords
alkyl
carbon atoms
terminal position
amided
production
Prior art date
Application number
CO99007017A
Other languages
English (en)
Inventor
Rainer Albert
Elsebeth Andersen
Alexander Hagenbach
Christoph Heusser
Papageorgiou Christos
Schreier Max H
Anette Wienand
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9802842.6A external-priority patent/GB9802842D0/en
Priority claimed from GBGB9810688.3A external-priority patent/GB9810688D0/en
Priority claimed from GBGB9826553.1A external-priority patent/GB9826553D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO4980854A1 publication Critical patent/CO4980854A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con un compuesto de lafórmula A: en donde cualquiera de: 1) Z es O; n es 0; T es un residuo: en donde: R6 es H; alquilo de 1 a 6 átomos de carbono opcionalmente sustituido en la posición terminal por halógeno, OH, NR7 R8 , COOH, CO-O-alquilo de 1 a 4 átomos de carbono, o CO-NR7 R8 ; alquilo de 1 a 6 átomos de carbono interrumpido por uno o más heteroátomos seleccionados a partir de N, o ó S, y sustituido en la posición terminal por halógeno, OH, NR7 R8 , COOH, CO-O-alquilo de 1 a 4 átomos de carbono, o CO-NR7 R8 ; OR9 ; NHR10 ; ciano; o formilo; Cada uno de R7 y R8 es independientemente H, alquilo de 1 a 4 átomos de carbono, ?-HO-alquilo de 1 a 4 átomos de carbono, CHO ó heterocicloalquilo de 1 a 4 átomos de carbono, o R7 y R8 forman junto con el átomo de nitrógeno con el que están enlazados, un anillo heterocíclico; R9 es alquilo de 1 a 6 átomos de carbono sustituido en la posición terminal por OH ó NR7 R8 ; R10 es un alquilo de 1 a 6 átomos de carbono sustituido en la posición terminal por OH ó NR7 R8 ; y W es un residuo: en donde: i) X es -CR1 =, en donde R1 es H, F, CF3 , alquilo de 1 a 4 átomos de carbono, ó NH2 ; ...
CO99007017A 1998-02-10 1999-02-08 Inhibidores de celulas b particularmente amidas, proceso par su produccion y composiciones farmaceuticas que los contiene CO4980854A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9802842.6A GB9802842D0 (en) 1998-02-10 1998-02-10 Organic compounds
GBGB9810688.3A GB9810688D0 (en) 1998-05-19 1998-05-19 Organic compounds
GBGB9826553.1A GB9826553D0 (en) 1998-12-02 1998-12-02 Organic compounds

Publications (1)

Publication Number Publication Date
CO4980854A1 true CO4980854A1 (es) 2000-11-27

Family

ID=27269204

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99007017A CO4980854A1 (es) 1998-02-10 1999-02-08 Inhibidores de celulas b particularmente amidas, proceso par su produccion y composiciones farmaceuticas que los contiene

Country Status (5)

Country Link
AR (1) AR015514A1 (es)
AU (1) AU2832399A (es)
CO (1) CO4980854A1 (es)
PE (1) PE20000281A1 (es)
WO (1) WO1999041239A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112594B2 (en) 2000-08-09 2006-09-26 Mitsubishi Pharma Corporation Fused bicyclic amide compounds and medicinal use thereof
CA2430951A1 (en) * 2000-12-07 2002-06-13 Cv Therapeutics, Inc. Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
EP1377549A1 (en) * 2001-03-12 2004-01-07 Millennium Pharmaceuticals, Inc. Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
MXPA04001286A (es) * 2001-08-15 2004-05-27 Du Pont Arilamidas orto-heterociclicas sustituidas para controlar plagas de invertebrados.
JP4361800B2 (ja) 2001-12-21 2009-11-11 サイトキネティックス， インコーポレイテッド 心不全を処置するための組成物および方法
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US8686048B2 (en) 2010-05-06 2014-04-01 Rhizen Pharmaceuticals Sa Immunomodulator and anti-inflammatory compounds
CA2804225C (en) * 2010-07-02 2018-05-01 Aska Pharmaceutical Co., Ltd. Heterocyclic compound and p27kip1 degradation inhibitor
EP2672963A4 (en) 2011-02-08 2015-06-24 Childrens Medical Center METHOD FOR THE TREATMENT OF MELANOMA
US9499484B2 (en) * 2012-04-02 2016-11-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Indole, indoline derivatives, compositions comprising them and uses thereof
ES2682493T3 (es) 2013-10-25 2018-09-20 Novartis Ag Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de FGFR4
US20180185341A1 (en) 2014-10-03 2018-07-05 Novartis Ag Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
US9802917B2 (en) 2015-03-25 2017-10-31 Novartis Ag Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
US10730839B2 (en) * 2016-11-27 2020-08-04 Russell Dahl Quinolines as cytoprotective agents
CN111164075A (zh) * 2017-09-20 2020-05-15 北京加科思新药研发有限公司 用作fgfr4抑制剂的稠环衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1305458A (es) * 1969-02-26 1973-01-31
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
FR2121394A1 (fr) * 1971-01-08 1972-08-25 Anvar Procédé d'obtention de dérivés d'acides indole carboxyliques et produits préparables par ce procédé.
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands

Also Published As

Publication number Publication date
PE20000281A1 (es) 2000-05-15
AU2832399A (en) 1999-08-30
AR015514A1 (es) 2001-05-02
WO1999041239A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
CO4980854A1 (es) Inhibidores de celulas b particularmente amidas, proceso par su produccion y composiciones farmaceuticas que los contiene
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
CO5040071A1 (es) Derivados de aminas biciclicas, procesos para su prepara- cion, y composiciones insecticidas que los comprenden
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
AR018892A1 (es) Compuestos de aminotiazol carbono-sustituidos, utiles como inhibidores de quinasas dependientes de ciclinas y las composiciones farmaceuticas que lascontienen, metodo para el tratamiento de enfermedades proliferativas, inflamacion y artritis
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
GB9806692D0 (en) Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
HUP0004227A2 (hu) Eljárás orto-helyzetben közvetlen fémbevitelre 5-(2-szubsztituált-fenil)-tetrazol-származékok előállításánál
CO4990932A1 (es) Derivados de 2,1,3-benzotiadiazol y proceso para su preparacion
HUP0004020A2 (hu) Triciklusos triazolo-benzazepin-származékok, eljárás a vegyületek előállítására és alkalmazásuk antiallergiás szerként
NZ332923A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
DK178388A (da) Tricykliske aminer afledt af 2,3,5,6,7,8-hexahydronaphtho-(2,3-b)furan og af 2,3,6,7,8,9-hexahydro-5h-benzocyklohepta-(2,3-b)furan, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
MY125037A (en) 1,2,3,4 tetrahydroquinoline derivatives
ES2160158T3 (es) Derivados de 4-indol-1-il acido butirico, su preparacion y su utilizacion como inhibidores de receptores alfa1-adrenergicos y testosterona 5alfa-reductasas.
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
MXPA04003568A (es) Aralquil-tetrahidro-piridinas su preparacion y composiciones farmaceuticas que contienen las mismas.
DK1163258T3 (da) Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
DK0812838T3 (da) Pyridoncarboxylsyrederivater substitueret med bicyclisk aminogruppe, estere og salte deraf og bicyclisk amin som mellemprodukt
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
NO955071L (no) abeo-Ergolin-derivater som 5HT1A-ligander
UA83638C2 (ru) Соединения 4-оксо-4,6,7,8-тетрагидропирроло[1,2-a]пиразин-6-карбоксамида, способ их получения и фармацевтическая композиция, которая их содержит
PE20001035A1 (es) Derivados de benzoxazina y benzotiazina como inhibidores de monoxido de nitrogeno sintasa
HUP0003321A2 (hu) Eljárás 2-alkiltiobenzonitril-származékok előállítására
EA200900922A1 (ru) НОВЫЕ СОЕДИНЕНИЯ ТРИАЗАБЕНЗО[α]НАФТО[2,1,8-cde]АЗУЛЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ